INTRODUCTION
Members of the cysteine-and glycine-rich protein (CRP) family are characterized by the presence of two tandemly arranged LIM domains linked to short glycine-rich regions [1] . So far, three members of the CRP family (CRP1, CRP2 and CRP3\MLP, in which MLP stands for muscle LIM-domain protein) have been characterized in vertebrates [2] [3] [4] . They exhibit a tissue-specific distribution with a unique dual subcellular localization [5, 6] . CRP1 expression is detected in a variety of organs enriched in smooth muscle, CRP2 is restricted to arteries and fibroblasts, and CRP3\MLP is dominant in organs enriched in striate muscle [3, 7, 8] . Mice deficient in CRP3\MLP exhibit defects in the architecture and function of both striate and cardiac muscle [9] . Biochemical studies as well as immunofluorescence experiments suggest that CRPs are involved in promoting protein assembly along the actin-based cytoskeleton [7, 10] . As a common biochemical property they can associate with the actin cytoskeleton and are capable of interacting with α-actinin and zyxin when overexpressed in adherent fibroblasts [5, 7, 11] . The C-terminal LIM domain (LIM2) of each CRP is predicted to have at least
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molecular complex. To identify these proteins and assign a cellular function to CRP2, a human cDNA library was screened with full-length CRP2 as bait in a yeast two-hybrid screen. The protein inhibitor of activated STAT1 (' PIAS1 ') was shown to associate selectively with the C-terminal LIM domain of CRP2.
Physical interaction of both proteins in the cellular environment was confirmed by co-localization experiments with confocal laser scanning microscopy and co-immunoprecipitation analysis. These results establish CRP2 as a potential new factor in the JAK\STAT-signalling pathway and suggest that the suppression of CSRP2 might be a prerequisite for the myofibroblastic transition of hepatic stellate cells.
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one protein partner and it was recently demonstrated that CRP3\MLP, but not CRP1 or CRP2, interacts in the cytosolic compartment with βI-spectrin [12] . CRP3\MLP also interacts with the basic helix-loop-helix myogenic transcription factors MyoD, myogenin and MRF4, increasing their affinity for specific DNA regulatory elements [6] . CSRP2, encoding the CRP2 protein, was originally isolated on the basis of its strong transcriptional suppression in fibroblasts transformed by viral oncogenes or chemical carcinogens [3] . Conditional cell transformation reveals that CRP2 is essential to the maintenance of normal cell function [1, 13] . The expression is strongly decreased in vascular smooth-muscle cells in response to platelet-derived growth factor (PDGF) or vessel wall injury induced by balloon injury of the carotid artery [14] . Common to the process of cell transformation and wound healing is a modified cytokine response of injured cells. Whereas PDGF is expressed at low levels in arteries from healthy adults, its expression is increased in conjunction with the inflammatory-fibroproliferative response that characterizes atherosclerosis [15] . It is noteworthy that both the injury of arterial tissue by balloon catheter and experimentally induced atherosclerosis are associated with an increased ex-pression of PDGF and up-regulation of PDGF receptors. This polypeptide growth factor is also thought to have a pivotal role in the cascade of events resulting in liver fibrosis, which is the wound-healing response to a variety of chronic inflammatory insults such as primary biliary cirrhosis, chronic hepatitis and toxic damage by alcohol. In necroinflammatory injury, quiescent hepatic stellate cells (HSCs) transdifferentiate to proliferatively active myofibroblastic cells (MFBs). Increasing numbers of HSCs during liver fibrogenesis arise from local proliferation in response to polypeptide growth factors [16, 17] . This fibrogenic activation is associated with the synthesis of PDGF and its receptors [18] . The aim of this study was to investigate the expression of CSRP2 in liver and to evaluate possible changes in its expression in injured liver and activated HSCs. Cell activation was induced either in itro by culturing quiescent HSCs on a plastic surface or in an in i o model of hepatic fibrosis induced by ligation of the common bile duct. We show that CSRP2 in liver is restricted to HSCs and that its expression is tightly controlled during the activation process. On the basis of the notion that CRP2 is a molecular adapter protein [19] , we also performed a yeast twohybrid screen to identify possible binding partners of CRP2. We found that CRP2 associates via its LIM2 domain with the protein inhibitor of activated STAT1 (PIAS1), which is a strong suppressor of the JAK\STAT (Janus kinase\signal transduction and activators of transcription) pathway [20] . On the basis of our results we propose that CRP2 might modulate a variety of developmentally and pathophysiologically relevant processes by interacting with essential mediators of cytokine-regulated pathways.
EXPERIMENTAL Isolation and culture of rat liver cells
Male Sprague-Dawley rats had access to Altromin chow and water ad libitum. Hepatocytes were isolated by the collagenase method of Seglen [21] , with slight modifications. In brief, animals were anaesthetized and liver was preperfused in situ via the portal vein followed by recirculating perfusion ex situ. Thereafter, the liver was perfused with collagenase and the capsule was gently removed. The tissue was dissected under constant swirling and the cell suspension obtained was subsequently filtered through nylon mesh (250 and 100 µm pore sizes), centrifuged and washed three times. Cells were seeded in DMEM (Dulbecco's modified Eagle's medium) (Bio Whittaker Europe, Verviers, Belgium) supplemented with 10 % (v\v) FCS (fetal calf serum ; Seromed, Berlin, Germany), 4 mM -glutamine (ICN Biomedicals, Aurora, OH, U.S.A.), 100 i.u.\ml penicillin, 100 µg\ml streptomycin and 0.02 i.u.\ml bovine pancreas insulin. HSCs, Kupffer cells and sinusoidal endothelial cells were isolated by the pronase-collagenase method [22] . Livers were therefore subsequently perfused with HBSS (Hanks buffered standard saline) (PAA Laboratories GmbH, Linz, Austria), with 0.35 % (w\v) pronase E in HBSS and with 0.015 % (w\v) collagenase in HBSS. Thereafter, livers were homogenized under permanent pH control (pH 7.3) in HBSS containing 100 µg\ml DNase type II (Roche, Mannheim, Germany). The suspension was filtered through nylon mesh, centrifuged and washed in ice-cold HBSS containing 0.25 % BSA. HSCs were further purified by singlestep density gradient centrifugation with 8.25 % (w\v) Nycodenz2 (Nycomed Pharma AS, Oslo, Norway) as described in detail elsewhere [23] . Kupffer cells and sinusoidal endothelial cells were collected by centrifugal elutriation [24, 25] 
RNA isolation and Northern analysis
Isolation and Northern analysis of RNA from rat liver cells or human cell line WI-26 VA4 (A. T. C. C., Manassas, VA, U.S.A.) were performed as described previously [3] . RNA from human kidney biopsies and rat livers was extracted after homogenization with an Ultra-Turrax2 (type TP18\10) and shearing DNA by pressing the resulting lysate three times through a 20-gauge needle before RNA isolation. Purified RNA was resuspended in water and the concentration was determined by UV absorbance.
Experimental model of cholestatic liver fibrosis
Male Sprague-Dawley rats (200-250 g body weight) were subjected to double ligature of the common bile duct with intersectional scission under anaesthesia [27] . Sham-operated rats that underwent laparotomy without bile duct ligation served as controls. The animals were killed 20 days after surgery. Before death, blood was aspirated from the portal vein and sera were analysed for alanine aminotransferase, aspartate aminotransferase and bilirubin to prove cholestasis and liver damage. Tissue pieces for in situ hybridization were directly fixed in 4 % (w\v) paraformaldehyde and embedded in paraffin. Cryostat sections for immunohistochemistry or staining with Oil Red O were snapfrozen in solid CO # .
Immunohistochemistry and staining with Oil Red O
A monoclonal antibody directed against α-smooth-muscle actin (α-SMA) (clone 1A4 ; Dako, Hamburg, Germany) was used to detect the expression of α-SMA. Immunohistochemical stainings were performed with indirect immunoperoxidase. In brief, paraffin-embedded 4 µm tissue sections were incubated with the α-SMA-specific antibody (1 : 500 dilution) ; a biotin-linked antimouse IgG (1 : 500 dilution) was used as the secondary antibody.
Immunoreactions were detected with the Vectastain-ABC kit (Vector Laboratories, Burlingame, CA, U.S.A.). Sections were counterstained with haematoxylin or haematoxylin-eosin. For Oil Red staining, rat liver cryostat sections were stained with 0.3 % (w\v) Oil Red O (Sigma, Deisenhofen, Germany) in 60 % (v\v) propan-2-ol for 10 min, washed in water and counterstained with haematoxylin or haematoxylin-eosin.
In situ hybridization of CSRP2 mRNA in mouse embryos and rat liver sections
The EcoRI fragment of pCRIII-rSmLIM [14] was cloned into pSPT18 (Roche). To generate riboprobes the plasmid was linearized with P uII or PstI and sense and anti-sense transcripts were produced with either the SP6 or the T7 RNA polymerase. Paraffin-embedded sections of NIH Swiss mouse embryos were pretreated with proteinase K (10 µg\ml) for 30 min at 37 mC, fixed in 4 % (v\v) paraformaldehyde\PBS (pH 7.0) for 5 min, washed twice in water and acetylated in acetic anhydride diluted 1 : 400 in 0.1 M triethanolamine (pH 8.0) for 10 min at room temperature. Slides were then washed twice in water, dehydrated in ethanol, dried in air and prehybridized for 4 h at 50 mC in hybridization solution containing 50 % formamide, 10 % dextran sulphate, 10 mM Tris\HCl, pH 8.0, 10 mM sodium phosphate buffer, pH 7.0, 2iSSC (where SSC is 0.15 M NaCl\0.015 M sodium citrate), 5 mM EDTA (final pH of solution, pH 8.0), 150 µg\ml tRNA, 10 mM dithiothreitol and 10 mM 2-mercaptoethanol. Hybridizations were performed overnight in the same mix supplemented with 5i10% c.p.m.\µl sense or anti-sense riboprobes at 50 mC. The slides were washed twice at 52 mC in 50 % formamide\2iSSC for 30 min. After treatment with RNase A (20 µg\ml) for 30 min at 37 mC, slides were washed five times with 50 % formamide\2iSSC at 55 mC for 1 h, rinsed in 2iSSC, dehydrated, coated with Kodak NTB2 emulsion and exposed to X-ray film for appropriate durations.
Construction of yeast expression plasmids
DNA corresponding to full-length human CRP2, amino acid residues 1-82 (LIM1) or residues 83-193 (LIM2) of human CRP2 was amplified by PCR with human CSRP2 cDNA as template [28] . The following primers were used : 5h-d(GAATTCATGCCTGTCTGGGGAGGTGG)-3h (P1) and 5h-d(CCATGGTTACTGGGCATGAACAAGAG)-3h (P2) for full length CRP2 ; P1 and 5h-d(CCTAGTTAAGCGTGCCAG-CGCC)-3h (P3) for LIM1 ; and 5h-d(GAATTCATGGACCGT-GGCGAGAGG)-3h (P4) and P2 for LIM2. Cycling products were ligated into the pGEM-T-Easy vector (Promega, Madison, WI, U.S.A.) and the integrity of cloned fragments was confirmed by sequencing. Restriction sites (underlined) introduced by PCR (EcoRI, NcoI) or included in the multiple cloning site of pGEM-T-Easy (EcoRI) were used to subclone into expression plasmid pLexA [29] , generating plasmids pLexA(hCRP2), pLexA [hCRP2(LIM1)] and pLexA[hCRP2(LIM2)], respectively. For the construction of pLexA(qCRP2) encoding full-length quail CRP2, the NotI fragment from clone W15 [3] was filled in by Klenow DNA polymerase and cloned into the filled-in BamHI site of pLexA.
Yeast two-hybrid interaction assays
Yeast cultures were grown under standard conditions in liquid medium or on solid medium with minimal synthetic dropout medium (Clontech, Heidelberg, Germany). All yeast transformations were performed by using a standard TE\lithium acetate method [30] with established modifications [31] [32] [33] . In brief, the reporter strain EGY48\p8op-lacZ [34, 35] was sequentially transformed with bait plasmid pLexA(hCRP2) and a human kidney Matchmaker LexA prey cDNA library (Clontech) cloned into pB42AD [29] . Transformants were screened for leucine auxotrophic marker (Leu) and β-galactosidase ( β-gal) activity. For characterization of individual positives, total yeast DNA preparation was performed with a glass beads\phenol\ chloroform embedded method [36] . With this DNA as template and with primers 5h-d(CCAGCCTCTTGCTGAGTG-GAGATG)-3h (P5) and 5h-d(GCAACCTGACCTACAGGAA-AGAG)-3h (P6), selective amplification of prey inserts by PCR was performed. PCR products were directly sequenced with primer P5. For the selective rescue of interesting prey vectors, total yeast DNA was transformed into Escherichia coli KC8 cells (hsdR, leuB600, trpC9830, pyrF ::Tn5, hisB463, lac∆X74, strA, galU, galK) and selected on M9 plates supplemented with ampicillin and thiamine. To determine the binding site of CRP2 with PIAS1, EGY48\p8op-lacZ yeast cells were simultaneously transformed with prey clone pB42AD-no75 and individual bait constructs. Selected transformants were picked and tested for reporter activity on minimal plates lacking Leu and supplemented
Construction of mammalian expression vectors
The 1305 bp EcoRI and XhoI fragment of pB42AD-no75 was filled in by Klenow DNA polymerase and ligated into pCMVMyc (Clontech), which had been cut by SalI and filled in. To construct pCMV-Myc-hCRP2 and pCMV-HA-hCRP2 the 592 bp blunted EcoRI\NcoI fragment of pLexA-hCRP2 was ligated into the filled-in SalI site of pCMV-Myc or pCMV-HA (Clontech) respectively.
Indirect immunofluorescence and confocal laser-scanning microscopy
NIH-3T3 cells were grown in DMEM supplemented with 10 % FCS, 4 mM -glutamine, 100 i.u.\ml penicillin and 100 µg\ml streptomycin. Coverslips for indirect immunofluorescence were preincubated in medium, rinsed in PBS and placed in six-well dishes. Approximately 3i10& cells in 2 ml were added to each dish and, after incubation for 16 h at 37 mC, cells were transfected using the FuGENE46 method (Roche). After incubation for 30 h, coverslips were washed three times in ice-cold PBS and cells were fixed for 15 min in 4 % (w\v) paraformaldehyde buffered in PBS (pH 7.4). Cells were then permeabilized for 2 min on ice in a solution containing 0.1 % sodium citrate and 0.1 % (v\v) Triton X-100 followed by three washes in PBS. Thereafter, cells were blocked for 30 min at 37 mC in 50% (v\v) FCS\0.1 % BSA in PBS and in 1 % (w\v) BSA\0.1 % fish gelatin in PBS. After washing, incubations with appropriate antibody solutions were performed at 37 mC for 1 h each in 0.1 % BSA in PBS followed by three washes in PBS. To reveal protein distributions, samples were analysed by confocal laser scanning microscopy (LS 410 Invert ; Zeiss, Oberkochen, Germany). Fluorescent dye labels were monitored simultaneously with a standard objective (40i 1.3 oil immersion), an external Ar laser (488 nm excitation, FITC signals) and an internal He\Ne laser (543 nm excitation, Cy-3 signals). Documentation was performed in either overlay mode or frame mode (consecutive overlay). Samples were analysed in confocal mode without sectioning, with an internal zoom factor of 3.0. A CRP2-specific antiserum [37] , a monoclonal anti-Myc antibody (clone 9E10 ; Clontech), a pre-adsorbed goat anti-(mouse-IgG) Cy-3 (Dianova, Hamburg, Germany), a biotinylated pig anti-(rabbit IgG) (Dako), a streptavidin-FITC conjugate (Dako) and a murine control IgG1 fraction (Santa Cruz, CA, U.S.A.) were used.
Co-immunoprecipitation
Transiently expressed Myc-CRP2 (or HA-CRP2) and Myc-PIAS1 were co-immunoprecipitated from the HEK-293 cell line with a polyclonal CRP2 antibody [37] . Immunopreciptation was performed using a protocol described previously [38] . Cell lysates for precipitation were prepared by lysing approx. 2i10( cells in 0.5 ml of immune precipitation assay buffer containing 1 % (v\v) Nonidet P40, 0.25 % sodium deoxycholate, 150 mM NaCl and 50 mM Tris\HCl, pH 7.5, supplemented with proteinase inhibitors (Roche). Immunocomplexes were recovered by the addition of 50 µl Protein A-Sepharose beads (Santa Cruz) and separated by SDS\PAGE. After transfer on to nitrocellulose membranes (0.45 µm pore size ; Schleicher & Schuell) the blots were probed with a monoclonal antibody against the Myc epitope followed by incubation with an anti-mouse IgG coupled to horseradish peroxidase. Horseradish peroxidase signals were detected with the Super signal detection system (Pierce).
Chomosomal mapping by fluorescence in situ hybridization (FISH)
FISH and chromosomal assignment were performed as described previously [28] . In brief, metaphase spreads were prepared from phytohaemagglutinin-stimulated human peripheral blood lymphocytes. The PIAS1 cDNA was labelled with biotin-16-dUTP in nick translation and was directly hybridized to the metaphase spreads. For the detection of hybridized biotinylated DNA, goat anti-biotin and rabbit anti-goat antibodies conjugated to FITC were used. Chromosomes and the exact subchromosome signal locations were identified by 4,6-diamidino-2-phenylindole (DAPI) banding and by linear interpolation of fluorescent peaks to standard chromosome ideograms with quantitative imageanalysing software.
Sequence analysis
All primers were obtained from MWG-Biotech AG (Ebersberg, Germany) and sequencing was done with the ABI Prism BigDye2 termination reaction kit (PE Applied Biosystems, Weiterstadt, Germany 
RESULTS

Expression of CSRP2 in rat liver
To establish CSRP2 expression in rat liver a Northern-blot analysis was performed with RNA extracted from the component cells of hepatic origin and kidney as a control ( Figure 1A) . A single transcript 1.0 kb in size was visible exclusively in HSCs and to a smaller extent in their transdifferentiated phenotype, i.e. the MFB. CSRP2 transcripts were virtually absent from whole liver, hepatocytes, sinusoidal endothelial cells and Kupffer cells. Thus, in liver, CSRP2 reveals a highly restricted cellular expression pattern. Subsequent analysis revealed that in itro the activation of HSCs is accompanied by an initial moderate upregulation of CSRP2 expression with a peak at the seventh day of primary culture. At later stages of transdifferentiation there was almost complete loss of CSRP2 transcripts in such cells ( Figure 1B) . In these analyses, the level of mRNA encoding the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal standard for the quality and amount of RNA present in each lane.
To rule out the possibility that the observed exclusive expression of CSRP2 in HSCs occurs only in cultured cells we performed in situ hybridization. The specificity of the CSRP2 anti-sense riboprobe was first demonstrated by in situ hybridizations with paraffin-embedded murine embryo specimens (Figure 2A) . The specific hybridization signals visible in the cardiovascular system, kidney, cortex and defined regions of the gastrointestinal tract were in agreement with previous reports [14] . No cross-hybridization was detectable with riboprobes in the sense orientation (results not shown). In sections of normal liver, CSRP2-specific signals were detected in the parasinusoidal space of Disse ( Figures 2B and 2C ). These observations agree with our Northern-blot analysis and indicate that CSRP2 was also expressed in i o exclusively in HSCs. To analyse whether the expression was changed during fibrogenesis in the setting of cholestatic liver injury, we used the model based on ligation of the common bile duct. At 20 days after surgery, animals showed the typical ductular reactions and ongoing liver fibrogenesis. In comparison with normal liver, drastic changes in architecture were observed by visual inspection of haematoxylin-stained sections ( Figures 3A and 3B ) and immunostaining for α-SMA ( Figures 3C and 3D) . In control livers, cells positive for α-SMA were noted in smooth-muscle cells of portal tract vessels and in a few cells surrounding terminal hepatic venules (Figure 3C) . In bile-duct-ligated rats, livers were highly enriched in α-SMA-positive HSCs forming layers around the bile ductules. In addition, α-SMA-positive cells in the periportal sinusoids were visible in the vicinity of ductular areas, which was consistent with the active recruitment of activated HSCs by ductular structures ( Figure 3D ). In addition, the loss of vitamin A droplets during hepatic fibrosis, as demonstrated by staining with Oil Red O, was taken as a consistent marker of successful induction of hepatic fibrosis ( Figures 3E and 3F) . Additionally, liver damage in these animals was further indicated by a significant elevation of serum levels for alanine aminotransferase (more than 120 units\l), aspartate aminotransferase (more than 750 units\l) and bilirubin (more than 13 mg\dl). We next examined the expression of CSRP2 in sections of normal and fibrotic livers. In comparison with control livers, the expression of CSRP2 along the sinusoids after bile duct ligation was markedly heterogeneous. Maximal expression was detectable in the stroma surrounding proliferating ductules ( Figures 3G and 3H) . Interestingly, MFBs in zones of complete fibrosis showed no expression of CSRP2. In summary, the results indicate (1) that the expression of CSRP2 in liver was restricted to HSCs and (2) that the expression was influenced by cholestatic liver injury. Consistent with our results obtained in itro was the observation that CSRP2 expression was initially up-regulated during HSCs activation and was lost in MFBs. The most effective stimulus for the proliferation of HSCs\MFBs yet described is PDGF. To investigate whether the expression of CSRP2 during transdifferentiation is influenced by this mitogen we performed stimulation experiments (Figure 4) . Administration of PDGF to HSCs resulted in an increased cell activation that was characterized mainly by retinoid loss and a phenotypic change into MFB morphology ( Figures 4A and 4B ). In comparison with unstimulated or TGF-β " -treated cells, CSRP2 mRNA was significantly increased in response to PDGF ( Figure 4C ). Although the intensities of 28 S and 18 S rRNA species revealed that each lane was loaded with comparable amounts of RNA, the expression of GAPDH was also increased in response to PDGF. This observation is in agreement with previous reports showing significant stimulation of GAPDH expression in quiescent cells in response to PDGF [39] . Interestingly, the cell line CFSC-2G derived from a carbon-tetrachloride-cirrhotic rat liver [40] also showed no CSRP2 expression. This cell line has a phenotype similar to transdifferentiated MFBs, as indicated by its ability to synthesize large quantities of α1(I)-procollagen, fibronectin and TGF-β, the hallmark of an MFB phenotype.
Identification of PIAS1 as a binding partner for CRP2
CSRP2 encodes the double-LIM-domain protein CRP2. This protein is proposed to function as an adapter molecule, arranging two or more protein constituents into a supramolecular complex.
Although members of the CRP\MLP family have affinity for α-actinin [9] , zyxin [41] , basic helix-loop-helix transcription factors [6] , βI-spectrin [12] and a novel protein (CRP2BP) with unknown function [37] , none of the identified binding partners allows the assignment of a cellular function. In an effort to identify proteins that bind to CRP2, we used the LexA-based interaction trap [29] . This sensitive yeast-based two-hybrid system [42] was previously used to identify CRP2BP [37] . In our interacting hunt, full-length human CRP2 encoding a protein of 193 residues was chosen as the bait. Because CSRP2 is highly expressed in human kidney ( Figure 5) , we decided to screen a commercially available human kidney Matchmaker library for interacting partners. In a representative screen of 4i10) yeast transformants with the Leu\X-Gal-based dual reporter system, we identified 89 prey clones positive for both reporters. Of these, 51 showed a Gal\Raf-dependent activation of both reporters. The clones were grouped into four major classes on the basis of their sequences (Table 1) . Isolated mitochondrial proteins known to interfere non-specifically with the interaction trap (http :\\www.fccc.edu\research\labs\golemis\InteractionTrap InWork.html) are listed in group 1. Some identified cDNA species of cytosolic proteins (group 2) such as cyclophilin, GAPDH and uromodulin were not fused in frame to the B42 activator domain. Elongation factor 1-α showed a low affinity for CRP2 and interaction was not analysed further. An artificial hydrophobic peptide and a phenylalanine-rich sequence isolated several times showed a strong interaction (group 3). These interactions might have been due to the overall hydrophobicity of those sequences and non-specific binding to hydrophobic patches within one or both LIM domains. However, two identified proteins were assigned to group 4 on the basis of their overall biochemical properties. Both proteins were able to interact with CRP2. We have recently described the identity of one of them [37] . The 1293 bp insert of the second interacting partner (prey clone 75) was sequenced. The cDNAderived amino acid sequence was 353 residues in length. A GenBank2 search with the BLAST algorithm at the NCBI (http :\\www.ncbi.nlm.nih.gov) revealed that the deduced amino acid sequence was identical to the C-terminus of PIAS1.
Determination of binding site
LIM domains of various proteins adopt a highly conserved tertiary structure. Both LIM domains (LIM1 and LIM 2) within CRP2 are independent folding units, separated by a flexible linker region [19] compatible with the proposed adapter function. If the interaction of CRP2 with PIAS1 is specific for CRP2 and not a general intrinsic property of the LIM domain itself, one would expect that PIAS1 would bind to one LIM domain of CRP2. To map the interacting interfaces and to determine the contribution of the individual LIM domains of CRP2 to its interaction with PIAS1, deletion constructs were prepared (Figure 6A) . As a further control, the quail CRP2 homologue (qCRP2), which was the first identified CRP2 [3] , was used as a bait in these interaction studies. As depicted in Figure 6 (B), positive growth and β-gal activity were detected in yeasts harbouring expression plasmids for quail CRP2, human CRP2 or the LIM2 domain of human CRP2 (encompassing residues 82-193). No reporter activity was monitored with the LIM1 domain of human CRP2 (encompassing residues 1-81). These
Table 1 Identification of CRP2-interacting proteins/peptides by interaction trap
The identities of proteins were deduced by the sequencing of individual prey inserts ; the reading frames of mitochondrial and cytosolic proteins vary from j1, j2 and j3 respectively. HSJ717M23* * The second interacting partner was recently published in detail elsewhere [37] .
results confirm the initial interaction of CRP2 and PIAS1 and reveal that LIM2 is necessary and sufficient for the interaction.
Co-localization and co-immunoprecipitation of CRP2 and PIAS1 in the cellular environment
Protein-protein interactions identified by the yeast two-hybrid assay need to be confirmed independently in the relevant biological system. To explore the CRP2-PIAS1 interaction in mammalian cells we transiently overexpressed full-length CRP2 and the Myc-tagged C-terminal part of PIAS1 in NIH-3T3 cells. The proper expression of both proteins was confirmed by Western blot analysis of cell extracts with an antibody specific for CRP2 or the Myc epitope (results not shown). Transiently expressed CRP2 alone displayed the typical subcellular localization with the reported actin-associated and nuclear distributions [5] (results not shown). The C-terminal part of PIAS1 containing a putative bipartite nuclear localization signal [KK(X) * KK] (single-letter amino acid codes) at amino acid position 367-379 showed, when expressed in NIH-3T3 cells, essentially the same nuclear localization as that published previously for full-length PIAS1 [43] (results not shown). Untransfected controls showed only weak immunostaining with the CRP2-specific antiserum and no staining with the Myc-epitope-specific antibody (results not shown). Confocal laser scanning microscopy of cells transiently expressing both proteins revealed that CRP2 and PIAS1 were co-distributed along the cytoskeleton and within the cell nucleus ( Figures 7A  and 7B ). The co-localization of both proteins is consistent with their interaction in cytosol and nucleus ( Figure 7C ). Independent verification of the interaction between CRP2 and PIAS1 was subsequently performed by co-immunoprecipitation assays. Cell lysates from the HEK-293 cell line transiently expressing CRP2 derivatives, a Myc-epitope-tagged PIAS1 or both were incubated with a CRP2-specific antisera, and co-precipitating PIAS1 was detected by Western blotting with a monoclonal antibody against the Myc epitope. As shown in Figure 7 (D), PIAS1 specifically coprecipitated with CRP2 in this assay.
Chromosomal localization of the human PIAS1 gene locus
Although PIAS1 was assigned during the Human Genome Project to chromosome 15 (see accession number NT-010351), the exact chromosomal location of PIAS1 is unknown. We
Figure 6 Interaction of PIAS1 with the LIM2 domain of CRP2
(A) Human full-length CRP2 (hCRP2), quail full-length CRP2 (qCRP2), the LIM1 domain of human CRP2 [hCRP2(LIM1)] and the LIM2 domain of human CRP2 [hCRP2(LIM2)] were fused to the LexA DNA-binding moiety (LDB). (B) PIAS1 (residues 298-650) was tested for binding activity with hCRP2, qCRP2, hCRP2(LIM1) or hCRP2(LIM2). Transformants were selected on SD/kUra/kHis/kTrp minimal selection plates and two individual colonies each were spotted on SD/Gal/Raf/kUra/kHis/kTrp/kLeu/X-Gal/BU-salts minimal plates. Selection for interaction was performed for 40 h at 30 mC. Transformants were pLexA and pB42AD (spot 1), pLexA(qCRP2) and pB42AD-no75 (spot 2), pLexA(hCRP2) and pB42AD-no75 (spot 3), pLexA[hCRP2(LIM1)] and pB42AD-no75 (spot 4), pLexA[hCRP2(LIM2)] and pB42AD-no75 (spot 5), pLexA(hCRP2) and pB42AD (spot 6) and pLexA and pB42AD-no75 (spot 7). Both yeast cell growth (Leu + ) and colour development (β-gal + ) were used as criteria for positive interaction.
therefore performed a precise mapping of PIAS1 by the FISH technique. As expected, specific fluorescent signals were obtained on chromosome 15 with a PIAS1-specific probe (Figure 8 ). In addition to direct visualization of the fluorescent profile signals on the DAPI\propidium iodide-banded chromosomes, we used the comparative genomic hybridization (' CGH ') analysis software to determine the chromosomal locations of the hybridized probes. Both methods showed that the PIAS1 hybridization doublets were localized to chromosome sub-band 15q22.
DISCUSSION
CSRP2 was originally discovered on the basis of its strong suppression in avian fibroblasts transformed by retroviral oncogenes or chemical carcinogens [3] ; the suppression of CSRP2 and its gene product, CRP2, was later directly linked to the transformed phenotype of fibroblasts in conditional transformation systems [1, 13] .
In accordance with cellular transformation, quiescent HSCs undergo mitogenic activation during the process of transdifferentiation. Active proliferation, increased expression of extracellular matrix components, enhanced contractility and the secretion of fibrogenic mediators are the main characteristics of MFBs. This process has attracted considerable attention because it is the key event in the pathogenesis of liver fibrosis. We studied the expression of CSRP2 in this process by using models both in itro and in i o. CSRP2 expression in liver is restricted to HSCs and the activation of HSCs is accompanied by an initial moderate up-regulation of CSRP2 and a suppression in later stages of transdifferentiation. Our Northern analysis further reveals that the initial increase in CSRP2 mRNA during transdifferentiation can be influenced by the administration of PDGF. In liver this cytokine is the most potent mitogenic stimulus for HSCs in i o [44, 45] and has marked effects on HSCs in culture. PDGF is also the major trigger for fibroblasts and smooth-muscle cells. It is noteworthy that CSRP2 is expressed in all these PDGF-sensitive cells. These findings suggest that CRP2 function is linked to cytokine (PDGF) signalling pathways. In this context it is notable that overexpression of the closely related CRP3\MLP in myoblasts favours myogenic differentiation by decreasing their sensitivity to TGF-β " and that the expression of CSRP1 encoding CRP1 is stimulated by serum factors [4, 46] .
The three-dimensional structure of CRP2 predicts a function as a molecular adapter protein [19] . To assign a distinct cellular function for CRP2 in the cytokine network we performed a yeast two-hybrid screen and found that PIAS1, a potent inhibitor of the JAK\STAT pathway, can interact with CRP2. This interaction of PIAS1 and CRP2 was demonstrated by three independent methods. First, we used CRP2-deletion constructs in the interaction trap to test the specificity of the observed interaction. The LIM2 domain of CRP2 is necessary and sufficient for binding to PIAS1, showing that the interaction is specific for that LIM domain and is not due to the general hydrophobic core structure present in LIM domains. Secondly, we performed co-localization experiments with recombinant proteins transiently expressed in mammalian cells. We demonstrate that CRP2 can bind to the last 353 residues of PIAS1 under cellular conditions, revealing that PIAS1 is a binding partner of CRP2 in i o. Thirdly, the interaction between CRP2 and PIAS1 could be independently demonstrated by co-immunoprecipitation studies in the HEK-293 cell line. The closely related CRP3\MLP protein was shown previously to associate in i o through the LIM1 domain with the muscle basic helix-loop-helix transcription factor MyoD in nucleus [6] and via the LIM2 domain with βI-spectrin in the cytosolic compartment [12] . Interestingly, in our experiments binding of CRP2 and PIAS1 is also observed in the nucleus and along the cytoskeleton in the cytosolic compartment.
PIAS1 is a pleiotropic protein effector with at least three distinct cellular functions. It was demonstrated that PIAS1 binds to the Gu\RNA helicase II [43] , specifically inhibits STAT1-mediated gene activation [20] and functions as a nuclear receptor transcriptional co-regulator [47] . The adapter protein CRP2 might therefore interfere with the function of all these proteins by sequestering PIAS1 and masking relevant binding interfaces. Consistent with this hypothesis is the observation that PIAS1-STAT1 interaction is mediated through the CRP2-susceptible C-terminus of PIAS1 [48] (see Figure 6 ). It is conceivable that anchoring PIAS1 at the cytoskeleton or binding PIAS1 in the nucleus is associated with a suppression of PIAS1 Figure 7 Interaction of CRP2 and PIAS1 in cellular environment (A and B) (magnification i1000) c-Myc-epitope-tagged PIAS1 (residues 298-650) and human CRP2 were transiently transfected into NIH-3T3 fibroblasts. Double-labelling immunocytochemistry was used to determine the distribution of subcellular proteins. Antisera for the detection of PIAS1 were c-Myc monoclonal antibody (clone 9E10) and goat anti-mouse-IgG-Cy 3 (red channel). Antibodies for the detection of CRP2 were polyclonal antibody against CRP2, following biotinylated pig anti-rabbit antibody and FITC-conjugated streptavidin (green channel). Double-transfected NIH-3T3 cells were monitored for regional co-localization by confocal laser scanning microscopy along the z-axis. 
Figure 8 Chromosomal mapping of human PIAS1
Immunodetection of hybridized DNA from PIAS1 cDNA revealed with an FITC-specific filter combination on chromosomes counterstained with DAPI/propidium iodide. Fluorescent signals on the two homologous chromosomes are indicated by arrows. The inset shows a direct visualization of hybridization spots on DAPI-banded (blue channel) chromosomes (left) and the average ratio between green (FITC channel ; biotinylated probe) and red (TRITC channel ; propidium iodide counterstain) for two measured chromosomes compared with the respective ideogram (right). The assignment of the fluorescence peak to the corresponding sub-band is indicated by an arrow. function and activation of the JAK\STAT pathway. It is of interest to note that CRP proteins have three possible types of cellular distribution (nuclear, F-actin-associated, or both nuclear and F-actin-associated) within one cell type [5] , raising the hypothesis that the distribution of CRP2 and CRP2\PIAS1 complexes has an impact on CRP2 function. A lack of CRP2 as a result of oncogenic transformation or cytokine-induced cell activation leads to higher concentrations of active PIAS1 and therefore to altered amounts of free STAT factors, Gu\RH-II helicase or androgen receptors. Conceivable with that hypothesis is the observed overall altered gene expression during the pathogenesis of liver fibrosis and cellular transformation.
In addition, it has been demonstrated that PDGF directly activates JAKs and STATs [49, 50] . It is possible that this activation is in part mediated by an altered expression of CSRP2. Indeed, we have shown recently that adenoviral overexpression of CRP2 is sufficient to potentiate the sensitivity of HSCs to PDGF (E. Van de Leur, A. M. Gressner and R. Weiskirchen, unpublished work).
Further studies are now required for an understanding of the fine-tuning of the JAK\STAT\PIAS\CRP2 network and its potential impact on oncogenic transformation and liver fibrosis.
